Michelle Zatlyn sells 76,923 shares for $17.6M over 3 days under pre-arranged 10b5-1 plan; reduces non-derivative holdings by 61.9%
Michelle Zatlyn, President and Board Co-Chair, executed 23 separate sales totaling 76,923 shares for $17,557,834.27 at a blended average price of $228.25 on 2026-06-16 through 2026-06-18 under a pre-arranged 10b5-1 trading plan adopted on 2025-02-14. This transaction reduced her non-derivative holdings from 124,348 shares to 47,425 shares, a 61.9% reduction of her non-derivative position. However, significant derivative holdings remain across the filing: 1,338,454 employee stock option shares, 1,312,813 employee stock option shares, 1,287,172 employee stock option shares, and three separate tranches of 25,641 Class B common shares, totaling 4,015,362 shares in derivative securities, indicating the insider's overall economic position in the company remains substantial. As a scheduled trade under a 10b5-1 plan rather than a discretionary transaction, this sale reflects pre-planned capital allocation rather than a current judgment about valuation; investors should note the company reported $-22.9M net loss on $639.8M revenue in the latest quarter, though annual revenue growth was +29.8%.